Skip to content
Screener

Thermo Fisher Scientific TMO Contract Liabilities, Non-Current

Contract Liabilities, Non-Current at other companies

Quanterix Corporation logo
Quanterix CorporationQTRX
$2.5M+137%
908 Devices logo
908 DevicesMASS
$11.01M+20.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
——
IR
Ingersoll RandIR
——

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$219.63B+25.8%
Enterprise value$254.75B+22.8%
P/E31.5×+5.0×
P/S4.9×-1.0×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)March 28, 2026December 31, 2025
Current contract assets, net$1,684$1,666
Noncurrent contract assets, net11
Current contract liabilities2,9282,710
Noncurrent contract liabilities1,0341,183

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's contract liabilities, non-current?
Thermo Fisher Scientific (TMO) reported contract liabilities, non-current of $1.03B in Q1 2026.
How has Thermo Fisher Scientific's contract liabilities, non-current changed year-over-year?
Thermo Fisher Scientific's contract liabilities, non-current decreased by 8.3% year-over-year, from $1.13B to $1.03B.
What is the long-term trend for Thermo Fisher Scientific's contract liabilities, non-current?
Over 5 years (2020 to 2025), Thermo Fisher Scientific's contract liabilities, non-current has grown at a 9.2% compound annual growth rate (CAGR), from $763M to $1.18B.

Ask your AI about Thermo Fisher Scientific's contract liabilities, non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude